Gilead Sciences (GILD) - 25 Year Stock Price History

Historical daily stock prices for Gilead Sciences since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Gilead Sciences (GILD) as of August 17, 2017 is 72.34.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.790B $30.390B
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective.